The Australian GP Alliance represents doctor-owned general practices across Australia, and we must express our profound concern and frustration regarding the recent announcement of funding changes for chronic disease management item numbers, effective from November 1st, 2024. This decision, coupled with the lack of timely communication and certainty, is not only imprudent but also detrimental to the healthcare system and the patients we serve.

Impact on Patient Care

Chronic disease management is a cornerstone of primary healthcare, providing essential support to patients with long-term conditions. These services are meticulously planned and booked months in advance to ensure continuity of care. The abrupt reduction in funding, without adequate notice or detailed information on the new rebates, jeopardizes the quality of care that our patients rely on. This uncertainty is causing significant distress among general practitioners and their patients, who are left in limbo regarding their ongoing treatment plans.

Economic and Health Consequences

Australia is currently facing an epidemic of chronic illnesses, which are leading causes of poor health, disability, and premature death1. Reducing funding for chronic disease management at a time when the burden of these conditions is escalating is counterproductive. It undermines the efforts of GPs who are at the frontline, managing these complex conditions and preventing hospital admissions. The financial strain on patients, particularly those in rural and remote areas, will likely increase, exacerbating health inequities and placing additional pressure on an already overburdened healthcare system.

Call for Immediate Action

We urgently call on the Federal Government to reconsider this decision and provide immediate clarity on the new funding arrangements. It is imperative that any reforms to the Medicare Benefits Schedule (MBS) do not result in a net reduction of funding for chronic disease management. We also request a delay in the implementation of these changes to allow general practices sufficient time to adjust and plan accordingly.

Conclusion

The health and well-being of millions of Australians depend on the stability and adequacy of funding for chronic disease management. We urge the government to engage in meaningful consultation with healthcare providers and stakeholders to ensure that any changes to the MBS support, rather than hinder, the delivery of high-quality, patient-centered care.

MBS Comparison